Table 3.
Distribution of HCC patients' characteristics and the clinical correlation with the lncRNAs signature (n = 235).
| Clinical parameter | Group | n | Risk score | ||
|---|---|---|---|---|---|
| Mean | SD | P value | |||
| Age | ≤55 | 95 | 1.402 | 1.550 | 0.30946 |
| >55 | 140 | 1.208 | 1.241 | ||
| Gender | Female | 74 | 1.218 | 1.348 | 0.60302 |
| Male | 161 | 1.318 | 1.389 | ||
| Grade | G1-2 | 132 | 1.084 | 0.940 | 0.01671 |
| G3-4 | 103 | 1.546 | 1.754 | ||
| Stage | Stages I-II | 163 | 1.200 | 1.377 | 0.14686 |
| Stages III-IV | 72 | 1.482 | 1.356 | ||
| T | T1-2 | 167 | 1.193 | 1.362 | 0.10477 |
| T3-4 | 68 | 1.517 | 1.388 | ||
| M | M0 | 231 | 1.294 | 1.385 | 0.00021 |
| M1 | 4 | 0.835 | 0.12 | ||
| N | N0 | 231 | 1.293 | 1.385 | 0.00728 |
| N1 | 4 | 0.908 | 0.166 | ||